PRS12 Budget Impact Analysis of Tiotropium Bromide Versus Ipratropium Bromide on the Top of Standard Therapy in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Russian Federation
Jun 1, 2012, 00:00
10.1016/j.jval.2012.03.296
https://www.valueinhealthjournal.com/article/S1098-3015(12)00361-0/fulltext
Title :
PRS12 Budget Impact Analysis of Tiotropium Bromide Versus Ipratropium Bromide on the Top of Standard Therapy in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) in Russian Federation
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)00361-0&doi=10.1016/j.jval.2012.03.296
First page :
A53
Section Title :
Respiratory-Related Disorders
Open access? :
No
Section Order :
1075